| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.201/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.201 |
| Version | 20200902 |
| Status | active |
| Date | 2020-09-02T01:00:24-04:00 |
| Name | Epirubicin |
| Title | Epirubicin |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value set contains concepts that represent the medication Epirubicin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Epirubicin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.) |
No resources found
| CodeSystem | |
http://www.nlm.nih.gov/research/umls/rxnorm  | RxNorm |
| http://www.nlm.nih.gov/research/umls/rxnorm | RxNorm |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200 | Epirubicin Injectable |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.1444.5.201",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "American Society of Clinical Oncology Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-05-23"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2020-09-02"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.201",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.1444.5.201"
}
],
"version" : "20200902",
"name" : "Epirubicin",
"title" : "Epirubicin",
"status" : "active",
"experimental" : false,
"date" : "2020-09-02T01:00:24-04:00",
"publisher" : "American Society of Clinical Oncology Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: This value set contains concepts that represent the medication Epirubicin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Epirubicin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:6636d56a-c66b-47d4-84ac-509f7aab5694",
"timestamp" : "2024-12-10T10:12:25-05:00",
"total" : 2,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1732182",
"display" : "25 ML epirubicin hydrochloride 2 MG/ML Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1732186",
"display" : "100 ML epirubicin hydrochloride 2 MG/ML Injection"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.